ESR1 and breast carcinoma: Fillmore et al. showed CD44+CD24neg/lowESA+ in both ER positive and ER negative breast cancer cell lines were enriched in stem cell properties and T-ISC, while the strongly surface CD24 positive CD44+ cells such as we observe in ER positive cancer lines were not (Fillmore & Kuperwasser, 2008).